Application for Faculty Position

CURRICULUM VITAE Name: YASSER SAYED BAYOUMI

Date of birth: 13/9/1969 Nationality: Egyptian Adress: 16 Ahmed Amen Street, Alharam, Giza Tel: 002 0100376996 00966502785290 E. MAIL: [email protected] Marital status: Married/2children Qualifications . Medical Doctorate degree (Radiation Oncology) National Cancer Institute, Cairo University, 2004 . Master Degree ( Clinical Oncology-Radiation Oncology) Kasr El Aini Faculty of Medicine, Cairo University,1998 . Bachelor Degree (Medicine and Surgery) Kasr El Aini Faculty of Medicine, Cairo University, 1993

Positions and Experiences:  Consultant Radiation Oncology (2009-currently) Radiation Oncology Department- Comprehensive Cancer Center King Fahd Medical City, Riyadh, KSA  Program Director of Radiation Oncology residency Program (2011- currently) Radiation Oncology Department- Comprehensive Cancer Center King Fahd Medical City, Riyadh, KSA  Chairman Radiation Oncology Department (2012-2014) CV Dr Yasser Bayoumi 12/2014 Radiation Oncology Department- Comprehensive Cancer Center King Fahd Medical City, Riyadh, KSA

 Associate Professor of Radiation Oncology ( 2009 -currently) Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University  Deputy Director and consultant Radiation Oncology (1998-2006) Part time Damietta Cancer Institute, Ministry of health, Egypt  Lecturer of Radiation Oncology (2004- 2009) Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University Egypt  MD program trainee (1998- 2004) Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University, Egypt  Master programs trainee (1995- 1998) Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University  House Officer (1994- 1995) Rotational training in all disciplines of Medicine and Surgery Kasr El Aini Faculty of Medicine, Cairo University

Society memberships: . Member of the Saudi Oncology Society (SOS) . Member of Saudi Society of Radiation Therapy (SSRT) . Member of the Egyptian Cancer Society. . Member of the Egyptian Group of Pediatric Oncology. . Member of Egyptian Group of Haematology

2 CV Dr Yasser Bayoumi 12/2014

Scientific activities: Establishing the scientific curricula 1. Sharing in establishing the curriculum and log book for radiation oncology residency program at KFMC, Riyadh, Saudia Arabia and then leading the program from the start till now 2. Sharing in establishing the training program / log book of MD degree of radiation oncology at NCI Cairo 3. Sharing in establishing the training program / log book of Egyptian Board of radiation oncology at MOH, Egypt. 4. Sharing in establishing the program of radiation therapy Diploma to graduate radiation therapist identified by SCHS 5. Establishing the curriculum of principles of radiation therapy for the Hematology Board, Saudia Arabia (SCHS identified) Teaching activities 1. Leading and director of the radiation oncology residency program at KFMC 2. Teaching doctoral students at National Cancer Institute the preliminary courses of Oncology substance basics radiotherapy. 3. Teaching of students of the Faculty of Medicine at King Fahd Medical City. 4. Teaching of the radiation therapy diploma students radiotherapy technology, radiobiology and applied clinical oncology. 5. Teaching students of the Faculty of Applied Health Sciences and King Saud University the principles of radiation therapy

3 CV Dr Yasser Bayoumi 12/2014 6. Teaching and training the residents of radiation oncology head and neck cancer, hematological malignancies and sarcoma.

Speaker at conferences and workshops 1. The ESTRO conference held in Amsterdam (Netherland 2004) lecture Adjuvant LTBI in advanced stage aggressive NHL 2. Panarab Oncology conference Ein Sokhna Egypt. The LTBI use in NHL. 2006 3. The Medical physics and radiation safety core of knowledge workshop at KFMC 2007,2008,2009,2010,2011, 2012,2013 and 2014 4. Training course and workshops in the planning radioactivity Modern radiotherapy planning systems held at King Fahd Medical City in 2008 Attendance of some selected conferences and workshops 1. Third Physics Course on Radiotherapy Planning held in National Cancer Institute, Cairo-Egypt. Within the framework of the European Union and IAEA, Jan.6-18, 1996. 2. First Pan Arab Cancer Conference, The Third French Arab Oncology Meeting, Fourth National Cancer Conference March 20-22, 1996 Cairo - Egypt. 3. Second Arab American Foundation Cancer Conference in collaboration with: The Egyptian Cancer Society, July 12-14, 1998 Alexandria, Egypt. 4. Cancer Registry Training Program organized and sponsored by Egyptian Ministry of Health and Population and the Epidemiological Division of Medicine at the University of California, Irvine, September 1-6, 1998.

4 CV Dr Yasser Bayoumi 12/2014 5. Sixth National Cancer Conference Spring Pan Arab Meeting Oncology Update 14-18 April 1999. Cairo, Egypt 6. The Third Alexandria Oncology (ESO) Course that held in Helnan Palastine Hotel, 13-15 October, 1999,Alexandria-Egypt. 7. ASCO-PANARAB Conference on Malignant Lymphoma And The Evolving Role Of Stem Cell transplantation 9-11 November 1999..Meridien Cairo Hotel,Egypt. 8. AWARD OF THE EGYPTIAN SOCIETY OF CANCER, 1999 about the research (The radiation dose to the contralateral breast during breast irradiation: the carcinogenesis risk) published in the Journal of the Egyptian National Cancer Institute. 9. NEMROCK Annual Meeting in Collaboration with Harvard University Hospitals: New Frontiers In Cancer Management; 30-31 March, 2000 10. NEMROCK Annual Meeting: STEREOTAXY; 10-12 March, 2001 11. Work Shop held by NEMROCK tilted STEREOTAXY; 12-14 March, 2001 12. ESTRO 23 meeting in Amsterdam, 24-28 October, 2004. with Oral Presentation about LTBI in NHL 13. Attendance of intensive Middle East Cancer Consortium Cancer Registry Training Program in cooperation with Rollins School of public health of Emory University February 21-25, 2005 Larnaca, Cyprus. 14. Attendance of conference of Dokuz Elluyl University “Turkey” with ESO: From 2D to 3D radiotherapy planning, Izmir 25-30 May,2005. 15. attendance of Medical physics and Tomotherapy conference, KFMC, KSA May, 2006 16. Attendence of Breast cancer symposium and work shop on the Highlights on the 29th San Antonio breast conference January, 2007 17. Attendence of Radiation Safety course at KFMC, KSA 30,31 October 2007

5 CV Dr Yasser Bayoumi 12/2014 18. Attendence of The Art Of IMRT Target Definition Course at 18-23 February, 2008 19. Attendence of Radiation Safety course at KFMC, KSA 15,16 March 2008 20. Perspectives in CNS Malignancies at Berlin Germany, 28-29 March,2008 21. International Saudi Haematology Congress at KFMC Riyadh, KSA May 2008 22. Attendence of Radiation Safety course at KFMC, KSA 1,2 November 2008 23. International academy of oral oncology and Gulf symposium on Head and Neck Surgery and Oncology. 25,26 November, 2008 24. Medical Physics Radiation Safety Course - King Fahd Medical City - Riyadh - Saudi Arabia, 08-09 Feb 2009. 25. Arab Association Against Cancer (AMAAC) 9th Pan Arab Cancer Congress, Translating Evidence to Practice7-9 May 2009 26. Attendance of Arab Association Against Cancer (AMAAC) 9th Pan Arab Cancer Congress, Translating Evidence to Practice7-9 May 2009 27. Attendance of San Antonio Update for Breast Cancer, the Four Seasons Hotel Riyadh, January 2010. 28. Attendance of Good Clinical Practice Training Course (GCP) @KFMC, Riyadh, KSA at 6 May, 2010 29. Attendance of the EPEC-O Professional course Education in Palliative and End of Life care conducted at King Abdulaziz Medical City Post graduate Training Center, Riyadh KSA @11-12 May, 2010. 30. Attendance of the EPEC-O Train-The Trainee course Education in Palliative and End of Life care conducted at King Abdulaziz Medical City Post graduate Training Center, Riyadh KSA @ 13 May, 2010. a. Attendance of San Antonio Update for Breast Cancer, the Intercontinental Hotel Riyadh, January 2011

6 CV Dr Yasser Bayoumi 12/2014

31. Attendance of The use of Molecular targeting therapy in cancer : new trends at Kuwait, Movenbeik, Albdaia, @ Feb, 2011. 32. Attendance of UE Cancer congress held at Grand Hayatt, Dubai, UAE @ 6-8 October 2011 33. Attendance of Training Course on IGRT and Respiratory Gating therapy held at Clatterbridge Oncology center, Wirral, UK @ 9-12 November 2011. 34. Attendance of the 1st European conference on SRS/SBRT and IGRT/IMRT: can we still treat without image guidance, 22-23 February 2013, Milan Italy. 35. Attendance of symposium in haematological malignancies (critical reviews), 7 March 2013. Riyadh Mariot KSA 36. Attendance of Saudi International Congress on New Frontiers in Organ Transplantation, 4-7 March, 2013, Mariot Riyadh KSA 37. Speaker / Attendance of Radiation safety course at KFMC, Riyadh Saudia Arabia 10-11 March, 2013. 38. Attendance of 3rd cancer pain management symposium at Riyadh, KSA 9-10 sep,2014. 39. Speaker / attendance radiation safety core of knowledge course and workshop at KFMC, Riyadh Saudia Arabia 10-11 October , 2014.

References:  Dr Abdullah Alamro Consultant Radiation Oncologist, King Fahd Medical City Riyadh Saudia Arabia. [email protected]

 Dr Musabbab Asiri

7 CV Dr Yasser Bayoumi 12/2014 Director of the cancer center King Fahd Medical City, Riyadh, Saudi Arabia. [email protected]

 Dr Abdulrahman Alhadab Chairman of Radiation Oncology Department National Guard Hospital, Riyadh, Saudia Arabia [email protected]

 Prof. Samy .A. El -Badawy Chairman of Radiation Oncology Department KFSH-DM, Dammam Saudia Arabia. Department of Radiation Oncology &Nuclear Medicine, National Cancer Institute,Cairo University [email protected]

 Dr Eyad Alsaeed Chairman of Radiation Oncology Department King Khalid University Hospital, Riyadh, Saudia Arabia [email protected]

 Dr Amr Aref Chief consultant radiation Oncology St John Hospital and Medical Center, MI, USA. [email protected]

 Dr Skye H. Cheng Duke University Medical Center, Durham, N.C. Senior Member, Department of Radiation Oncology and Chief, Clinical Protocol Office, Koo Foundation Sun Yat-Sen Cancer Center.Taiwan. [email protected]

Clinical Experience / Training: Currently working as Consultant Radiation Oncology at CCC, KFMC, KSA. And was working as Chairman of Radiation oncology Department till 12/2014

8 CV Dr Yasser Bayoumi 12/2014 Comprehensive Cancer Centre is an independent center affiliated to KFMC. It is one of the biggest comprehensive cancer centre of its kind in MOH, KSA. The KFMC includes a broad array of medical services and its departments include: internal medicine, orthopedics, surgery with all sub-specialties, intensive care and recovery unit, diagnostic endoscopy, anesthesiology, nuclear medicine, radiology, cardiac center, neuroscience department and brain suit. The Hematology and Oncology Center include palliative care, radiation oncology, medical oncology hematology and pediatric oncology units with attached bone marrow/stem cell transplantation section, clinical pharmacy, clinical pathology and blood bank, a laboratory for surgical pathology, a laboratory for cytopathology, cancer registration and epidemiology unit, a department for tumor biology and an electron microscopy unit. The radiotherapy department is equipped with 2 linear accelerators multi-energies with 120 MMLCs, 2 simulators one of them is CT simulator. In addition the Department has a mould room and a brachytherapy unit with both low dose rate and high dose rate after loading for both interstitial and intra-cavitary techniques. In addition the Department equipped with stereotactic radiotherapy facilities, and IMRT. Two planning systems: ECLIPSE treatment planning system and Brain lab planning system licensed for SRS, SRT and IMRT. The medical physics department affiliated to CCC is highly equipped with full dosimetry and QA systems. Job description I was the chairperson of the radiation oncology department defining the strategy of the work of the department and still leading the QA subcommittee and also leading the new cancer center radiation oncology department establishment; the new center will include the proton treatment which is the 1st of its kind in Africa and Middle East. As consultant radiation oncology, I am responsible for attendance of the clinics, simulation settings, treatment planning target definition and inpatient follow up. I am one of the KFMC team who started on establishing the

9 CV Dr Yasser Bayoumi 12/2014 Radiation Oncology Department which includes IMRT, SRS, SRT, HDR, 3D RT and Virtual Simulation. The job includes also clinical and experimental research activities, as well as training of residents and students of faculty of medicine and Faculty of Applied Science graduate.

Currently working as director of the radiation oncology residency program at CCC, KFMC, KSA. The radiation oncology residency program is a 5 year program for training of the radiation oncology residents including academic and practical training to radiation oncology also teaching a curricula for medical oncology, surgical oncology, radiographic anatomy, onco-pathology, clinical pharmacology, medical physics and treatment planning, radiobiology, biology and biostatistics. We are following the Can Med guidelines and standard and seeking for accreditation by different world wide bodies like FRCR; UK and Canadian Board. The program now identified by the FCPS Job description: establishment of the program and nominating the course coordinators ensuring the standards and arranging with different department. Interviewing the candidates and helping then to overcome the obstacles I am affiliated to NCI of Cairo University as Associate Professor radiation oncology National Cancer Institute is a specialized hospital and academic institute affiliated to Cairo University. The department is equipped with 5 Linear accelerators, 2 Cobalt-60 machines, a brachytherapy unit for various low dose and high dose rate intracavitary applications, HDR interstitial therapy techniques, and 3D treatment planning system, IMRT, SRS as well as SRT. The department accepts on average of 3500 new patients every year. The medical physics department affiliated to NCI Cairo is highly equipped with full dosimetry and QA systems and considered as reference Physics lab for ARE.

10 CV Dr Yasser Bayoumi 12/2014 Job description Involved in direct cancer patients’ care including inpatients as well as outpatients. . Radiotherapy of cancer patients with all the modern techniques of radiotherapy including o Conventional planning clinically and with the simulator o CT planning, 3D conformal radiotherapy, o Uses of different mega voltage machines (Cobalt and Linear Accelerator) and electron beam in the management of all types of cancer. o Brachytherapy (Manual and after loading { High dose rate and Low dose rate} ) Including intracavitary and interstitial application o Stereotactic radiotherapy o Total body irradiation for bone marrow transplantation o Total skin irradiation . Teaching for trainees registrar in radiotherapy department and instructions of house officer radiographers and post graduate interns . Supervision for the postgraduate candidates doing MSc in radiation Oncology

Also, I worked as Deputy Director of Damietta Cancer Institute (DCI) as part time 2 days a week. DCI is one of the biggest 6 cancer centers established by MOH, Egypt responsible for treating the patients, early detection, screening and prevention of cancer. I was responsible about establishing the Oncology computer system of the hospital, National Cancer Registery of the North East area of Egypt. Besides that, I was working as Radiation Oncologist responsible about treating H&N cancer, Lymphoma, Gynaeoncology and Total body irradiation

11 CV Dr Yasser Bayoumi 12/2014 Clinical training: I carried out a 3- years residency started at 1994 ended by Master degree graduation, followed by 5 years as assistant lecturer ended by Doctorate degree graduation at the Radiation oncology Department, National Cancer Institute (NCI) of Cairo University. The master degree program (3 year duration) the 1st year academic course of pathology, statistics, epidemiology, physics and radiobiology that ended by an oral and written examination, the following 2 years included clinical attachments  Oncologic malignancies diagnosis, management and training on various radiotherapy planning techniques for breast, gynecological malignancies (6 months)  Prostate, bladder cancer and brain tumors, bronchogenic (6 months)  Head and neck tumors, soft tissue tumors and skin tumors (6 months)  Lymphoma, pediatric malignancies (6 months) This followed by extra 6 month training on the high technology radiotherapy including Brachytherapy techniques, SRS, and TBI. The last 2 years include also thesis research project about: Techniqual Aspects and Quality Assurance of Radiotherapy Planning In Cancer Breast The Medical Doctoral and PhD program (5 years) including preliminary courses, thesis and management of cases under supervision ending by final oral, written and clinical exam for MD obtainment. The preliminary courses includes Principles of Medical Statistics, Cancer Epidemiology, Cancer pathology, Cancer biology, Cancer prevention, Cancer management, Radiobiology, Clinical radiotherapy, and Cancer patients' medical care each course ended by oral, practical and written exam. The thesis was about: The role low dose TBI as adjuvant treatment in management of Aggressive NHL. The management under supervision includes attendance of screening clinics, follow up clinic, combined clinics,

12 CV Dr Yasser Bayoumi 12/2014 simulation sessions, treatment planning, brachytherapy, IMRT and stereotaxy. The program includes also sharing in the scientific, administrative work and departmental meetings. The programming including fellowship in different systems 1 year each including Breast /Gynecology malignancies, H&N /CNS, Lymphoma/Pediatric, GIT/Urinary and SRS/TBI/TSI/Brachytherapy It also includes sharing in teaching the radiation oncology and radiotherapy techniques for residents and MSc candidates.

Research and published materials: 1. M.S.C Thesis about (Techniqual Aspects and Quality Assurance of Radiotherapy Planning In Cancer Breast) 1998, Kaser Alaini, Cairo University

2. Yasser Bayoumi, Hassan K. Awad, Magda El Mongi, Omar Zaki. The radiation dose to the contralateral breast during breast irradiation: the carcinogenesis risk. Published @ 6th National cancer conference” Spring Pan Arab Meeting: Oncology Update” 14-18 April 1999. Cairo, Egypt (Wins the 1st prize at the conference).

3. Akmal Safwat, Yasser Bayoumi et al,. The hematological toxicity of low dose total body irradiation in patients with non-Hodgkin's’ lymphoma in

13 CV Dr Yasser Bayoumi 12/2014 second relapse or more (poster presentation). Published @ ESTRO (Istanbul 19-23 September 2000).

4. MD thesis about (The adjuvant use of Low Dose Total Body Irradiation in aggressive NHL advanced stages) 2003, NCI, Cairo University

5. Safwat Akmal, Bayoumi Yasser, Elsharkawi Nahlah, Shaaban Khalid, Mansour Osman, Kamel Azza. The palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemo resistant non-Hodgkin’s lymphoma. Radiother Oncol 2003; 69: 33_/6.

6. Akmal Safwat, Yasser Bayoumi, Hany Akkoush and Hossam K. Mahmoud. A Phase II Trial of Adjuvant Low-dose Total Body Irradiation in non-Hodgkin’s Lymphoma Patients following Standard CHOP. Acta Oncologica, 2004;43(5):480-85.

7. Yasser Bayoumi, Bassiem Al beirouti, Mushabbab ALasiri, Syed Zaidi:The use of G-CSF in prevention of neutropenia and febrile neutropenia among KFMC patients with HD and NHL. Published @ 1st KFMC research conference,2006

8. Yasser Bayoumi. The Hematological Toxicity of Low Dose Total Body Irradiation Used in Treatment Of Non Hodgkins’ Lymphoma. Published @ 2nd KFMC research conference,2007

9. Osman Elhanafy, Yasser Bayoumi, Reham Abdulmoniem. Evaluation of Wedge Factor Measurements for High Energy Photon Treatment Field Using Physical Wedge. Mansoura University medical journa, Egypt,2007; Vol 3:15-18.

14 CV Dr Yasser Bayoumi 12/2014 10.Osman Elhanafy, Yasser Bayoumi. Photon Dose Calculation in Different Treatment Planning System. Medical Journal of Cairo University, 2007;75(6):213-218.

11.Osman Elhanafy, Yasser Bayoumi, Reham Abdulmoniem. Effect of Reconstruction methods on Prescription Points for HDR Brachytherapy gynecological Application. Mansoura University journal, 2007,Vol 4:167- 71

12.Abou-Saleh A.M. Elawadi* and Yasser Bayoumi. Study of the effect of ionization chamber effective point on percentage depth dose measurements. published @ International medical physics conference of KFSH-RC, 2008

13. Yasser Bayoumi, Osama El-malt. Efficacy Of Radical Radiotherapy In Medically Unfit Bladder Cancer Patients: Damietta Cancer Institute Experience. The Medical Journal of Cairo University.2008;76(4):251-259.

14.Yasser Bayoumi. Aida Radwan. Nahlah El Sharkawi. Low-dose Total Body Irradiation (LTBI) in patients with metastatic renal cell carcinoma: A feasibility study and immuno modulatory effect. The Medical Journal of Cairo University.2008;76(4):261-267.

15.Yasser Bayoumi, Reham Abd El-Moniem, Mushabbab Asiri, Eyad AlSaeed, Osman Elhanafy, Mokhtar Al-Shanqeeti, Abdullah Al Amro. Acute Toxicity of Pelvic Irradiation in Patients with Gynecological Tumors Associated with Systemic Lupus Erythematosis Treated with Intensity Modulated radiotherapy and Brachytherapy: Case series and Review of Literature. The Medical Journal of Cairo University.2008;76(4):243-250

16.Samy A. El-Badawy, MD, Yasser S. Bayoumi , MD, Reham Abd El- Moniem, Moneer Abo El-ella, MD, Ehssan El Ghoneimy, MD. Open-table

15 CV Dr Yasser Bayoumi 12/2014 Technique as A Method To Minimize Bowel Toxicity From Pelvic Irradiation In Cancer Rectum Patients. Published @ 4th KFMC research conference,2009

17.Yasser Bayoumi, Abdullah Al-Amro, Reham Abdul-Moniem, Imen Sohaibani, Osman Al-hanafy, Abousaeh Alawadi, Mushabbab Asiri. Assessment of three-dimensional set-up errors in head and neck cancer patients treated by Intensity Modulated radiotherapy using electronic portal imaging device. The Gulf Journal of Oncology. 2009; 6:39-44.

18.Reham Abd El-Moniem, Abdullah Al-Amro, Yasser Bayoumi, Abdelsalam Ismail, Abou-Saleh Elawadi, Abdurahman El-Hadab. The Safe Radiotherapy in Patients with Implanted Cardiac Pacemaker. The Medical Journal of Cairo University.2009;77(3):127-133.

19.Abou-saleh Elawadi, Yasser Bayoumi, Reem Alomran, Reham Abd El- Moniem, Abdullah Alamro. Does Intravenous Contrast Agent Affect Dose Calculations of Three Dimensional Treatment Planning System?. Published @ 4th KFMC research conference,2009

20.Abou-saleh Elawadi, Yasser Bayoumi, Reem Alomran, Reham Abd El- Moniem, Abdullah Alamro. Does Intravenous Contrast Agent Affect Dose Calculations of Three Dimensional Treatment Planning System. Bulletin Alex. Fac. Med., 2009; 45 (1): 101-106.. 21.Abou-Saleh A.M. Elawadi* and Yasser Bayoumi. Study of the effect of ionization chamber effective point on percentage depth dose measurements. published @ International medical physics conference of KFSH-RC, 2008, Medical Journal Cairo University. 2009 vol 77 (4):19- 22.

22.Reem Al Omran, Bassim Al Beirouti, Yasser Bayomi, Eyad Al Saeed, Abdulaziz Al Humaidi, & Syed Zaidi: The role of radiation therapy in the

16 CV Dr Yasser Bayoumi 12/2014 management of patients with HD and NHL attended to KFMC Prince Sultan Haematology Oncology Center. Published @ 4th KFMC research conference,2009.

23. Yasser Bayoumi, Reham Abdulmoniem, Abdullah Alamro. Steretactic Radiosurgery-Functional, Pain and other disorders; Neurosurgery tricks of the trade book. 2011: Chapter 131/978-1-60406-335-6c131- tvg22.xml Thiemes medical publisher. (ISBN: 978-1-60406-335-6).

24.Majed Mosely, Mohamed Hamada, Yasser Bayoumi, Eyad Alsaeed, Reham Abdulmoniem: Carotid Vessel dose in supraclavicular lymph node treatment in breast cancer patients: Is direct field technique optimal?. Published @ 6th KFMC research conference, 2011.

25.Yasser Bayoumi, Doaa Abdelmoety, Eyad Alsaeed, Abdulrahman Al Hadab, Reham Abdulmoniem, Abdulaziz Al Humaidi, Syed Zaidi, Bassem Al-Beirouti , Mushabbab Al-Asiri: Role of Radiotherapy in Advanced Stage Hodgkin Disease with Initial Bulky or Residual Disease Following Standard Chemotherapy: A Multi Institutional Retrospective Analysis. Published @ 6th KFMC research conference, 2011.

26. Abdullah AlAmro, Abdelsalam Ismail, Doaa Abdelmoety, Yasser Bayoumi: Phase III, Double-Blind, Placebo-Controlled Study of Post- Operative Adjuvant Concurrent Chemo-Radiotherapy With or Without Nimotuzumab for Stage III/IV Head and Neck Squamous Cell Cancer..Preliminary results in KFMC annual Research Conference 2011.

27. Muhammad Fareed, Abdullah Al Amro, Rashad Akasha, Mansour Al Assiry, Mushabbab Al Asiri, Mutahir Tonio, Yasserr Bayoumi: Parapharyngeal space hemangiopericytoma treated with surgery and postoperative radiation: a case report, Head & Neck Oncology 2012, 4:10. (http://www.headandneckoncology.org/content/4/1/10).

17 CV Dr Yasser Bayoumi 12/2014 28. M. Fareed, A. A. Al Amro, M. A. Tonio, M. Asiri, Y. Bayoumi, M. Mubasher, R. Akasha,: Intensity-modulated Radiotherapy With Simultaneous Modulated Accelerated Boost Technique In Patients With Nasopharyngeal Carcinoma- King Fahad Medical City Experience published @ ASTRO meeting 2012; Tracking Number: 2012-A-1402- ASTRO.

29. Mushabbab Al Asiri, Mutahir Ali Tunio, Abdul Rehman Alhaddab, Reham Mohamed, Yasser Bayoumi, Eyad Alsaeed, Abdullah Al Amro: Impact of Body Mass Index on Treatment Outcomes of Adjuvant Radiation Therapy in Saudi Females with Endometrial Carcinoma. World J Surg Med Radiat Oncol 2012;1:119-129. (http://www.npplweb.com/wjsmro/content/1/22)

30. Mutahir A. Tunio, Mushabbab A lAsiri, Yasser Bayoumi, Mohsin Fareed, Shoaib Ahmad: Thyroid gland as an initial site of delayed metastasis from renal cell carcinoma: A case report. JST.2012 (2)No. 4:50-52. (www.sciedu.ca/jst)

31. Mutahir A. Tunio, Mushabbab A lAsiri, Yasser Bayoumi, Mohsin Fareed, Shoaib Ahmad: Cervical lymph node metastasis from transitional cell carcinoma of urinary bladder: Case report and review of literature. JST; 2012 ( 2)No. 3:59-62. (www.sciedu.ca/jst)

32. M.A. Tunio, M. Al-Asiri, A. Al-Amro, Y. Bayoumi, and M. Fareed: Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis. Current Oncology; 2012: 19 (4) 280-288.

33. Mushabbab AlAsiri, Mutahir Ali Tunio, Abdullah Amro, Shoaib Ahmad, Yasser Bayoumi and Mohsin Fareed: Results of Intensity Modulated Radiation Therapy in Patients with Well Differentiated

18 CV Dr Yasser Bayoumi 12/2014 Thyroid Carcinoma: Experience of King Fahad Medical City. J Nucl Med Radiat Ther 2012. S6 1:5. (http://dx.doi.org/10.4172/2155-9619.S6-001)

34. Mutahir Tunio, Mushabbab Al Asiri, Abdul Rehman Alhadab, Yasser Bayoumi, Eyad Alsaeed, Khalid Riaz, Abdullah Amro, Abdel Salam Ismail and Abdulaziz Alobaid: Sequential Adjuvant Chemotherapy and Radiotherapy in Treatment of Early Stage Endometrial Carcinoma: Single Institutional Experience. J Nucl Med Radiat Ther 2012 S6, 1:6. (http://dx.doi.org/10.4172/2155-9619.S6-010)

35. Mushabbab Al Asiri, Mutahir Ali Tunio, Abdul Rehman Alhaddab, Reham Mohamed, Yasser Bayoumi, Eyad Alsaeed, Abdullah Al Amro: Impact of Body Mass Index on Treatment Outcomes of Adjuvant Radiation Therapy in Saudi Females with Endometrial Carcinoma. World J Surg Med Radiat Oncol 2012;1:119-129.

36. M. Tunio, M. AlAsiri, A.R. AlHaddab, R. Mohamed, Y. Bayoumi, M. Fareed, E. AlSaeed, A. AlAmro: Extended Field Chemoradiation for Radiologic Negative Para-aortic Lymph Nodes Locally Advanced Cervical Cancer published as oral presentation @ 2nd ESTRO Forum, Geneva, Switzerland from 19-23 April 2013, abstract number is GEN-0767.

37. Mutahir A.Tunio, MushabbabAlAsiri, AhmedM.Maklad, YasserBayoumi: Clinicopathological features and treatment outcomes of primary thyroid lymphomas in Saudi Arabia: A case series of seven patients. Cancer Treatment Communications Journal (2013) 1, 14–17.

38. Muhammad M Fareed, Abdullah A Amro, Yasser Bayoumi , Yasser Orz, Mutahir Tunio, Ahmad Maklad and Khalid Riaz: LINAC Stereotactic Radiosurgery for brain arteriovenous malformation: a single institutional experience from Saudi Arabia. Neuroscience Discovery Journal;2013:1-7. (http://www.hoajonline.com/journals/pdf/19-1-1.pdf)

19 CV Dr Yasser Bayoumi 12/2014 39. Yasser Bayoumi, Ahmed Marzouk Maklad, Mutahir Ali Tunio, Hanadi Fatani, Reham AbdelMonem Mohamed, Eyad Fawzi AlSaeed and Mushabbab Al Asiri: Clinicopathological features and treatment outcomes of primary laryngeal lymphomas in saudi population. Haematology and leukemia Journal, 2013:1-5. (http://www.hoajonline.com/journals/pdf/2052-434X-1-5.pdf)

40. Eyad Fawzi AlSaeed1,, AbdulRahman Jameel AlGhabbban, Mutahir A. Tunio and Yasser Bayoumi. Impact of body mass lndex on locoregional control in Saudi patients with breast cancer after breast conserving surgery and modified radical mastectomy. Global Epidemic Obesity Journal; 2014:1-7. (http://www.hoajonline.com/journals/pdf/2052-5966-2-1)

41. Eyad Fawzi AlSaeed , Mutahir A. Tunio , Yasser Bayoumi , Ahmad Zubaidi , Farjah Alqahatani. Knowledge, Attitude and Practices among Urban Women of Riyadh, Saudi Arabia Regarding Breast Cancer. Kuwait Medical Journal; 2014 accepted for publication.

42. M. Al Asiri, M.A. Tunio, Y. Bayoumi, R. Mohamed, E.Al Saeed, A. Al Hadab, A. Al Amro. Five Years Treatment Outcomes of Postoperative Radiotherapy in Saudi Women with Uterine Cancers. Gulf Journal of Oncology: 2014 (16):32-39.

43. Khalid Hussain AL-Qahtani, Mushabbab Al Asiri , Mutahir A. Tunio , Yasser Bayoumi, Naji J. Aljohani , Iqbal Munir, Ayman AlAyoubi. Nasolacrimal Duct Obstruction Following Radioactive Iodine 131 Therapy in Differentiated Thyroid Cancers: Review of 19 cases. Dovepress..2014. ISSN: 1177-5483. Clinical ophthalmology 2014:8; 2479-2484.

20 CV Dr Yasser Bayoumi 12/2014 44. Reham Abdulmoniem, Yasser Bayoumi, Mushabbab Al Asiri, Reem Zatar, Abdullah Al Amro, Majed Mosely, Mohamed Hamada, Eyad Al Saeed, Abdulrahman Al Hadab, Mutahir A. Tunio. Risk of Radiation Induced Carotid Artery Stenosis in Supraclavicular Lymph Node Irradiation in Breast Cancer Patients. Journal of Cancer Therapy, 2014, 5, 238-245. (http://dx.doi.org/10.4236/jct.2014.53031)

45. Mushabbab Al Asiri, Mutahir A Tunio, Reham Abdulmoniem, Yasser Bayoumi, Abdulrehman Alhadab, Rasha M Saleh, Muhannad Saud AlArifi, Abdelaziz Alobaid. Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer. Cancer Management and Research 2014:6 339–348.

46. Muhammad M Fareed, Abdullah S AlAmro, Yasser Bayoumi, Mutahir A Tunio, Abdul S Ismail, Rashad Akasha, Mohamed Mubasher, Mushabbab Al Asiri. Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma. BMC Cancer 2013, 13:318; 1-7. (http://www.biomedcentral.com/1471-2407/13/318)

47. Yasser Bayoumi, Ayman AbdelSamie, Ahmed Abdelsaid, Aida Radwan. Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy. Breast Cancer: Targets and Therapy. 2014:6 151–158. (http://dx.doi.org/10.2147/BCTT.S69309)

48. Yasser Bayoumi, Abdulaziz Al-Homaidi, Syed Zaidi, Imran Tailor, Samer Al-Modibiegh, Nawal Alshehri, Assem AL-Ghazali. Benefit of Consolidation Radiotherapy for Initially Bulky Sites Achieved Complete Remission or PET Negative Residual Disease in Advanced Stage Hodgkin

21 CV Dr Yasser Bayoumi 12/2014 Disease Following Standard Chemotherapy. Journal of Blood Medicine, Dovepress, 2014: ISSN: 1179-2736

49. Yasser Bayoumi, Tarek Heikal, Hossam Darwiesh. Survival Benefit of Post-Operative Radiotherapy Following Radical Cystectomy In stage III and IV Bladder Cancer: Results of 170 patients. Cancer Management and Research, dovepress,2014: ISSN: 1179-1322.

50. Yasser Bayoumi, Abdulrahman J Sabbagh, Reham Mohamed, Usama M ElShokhaiby, Ahmed Marzouk Maklad, Mutahir A Tunio, Ali Abdullah O Balbaid. Clinicopathological Features and Treatment Outcomes of Brain Stem Gliomas in Saudi children and adults ISSN 2218-4333. World Journal of clinical oncology; 2014 December 10; 5(5):1060-1067.

51. Muhammad Mohsin Fareed, Abdullah Al Amro, Yasser Bayoumi, Khalid HA AlQahtani, Hanadi A Fatani, Mutahar Ali Tunio and Farhan Khalid. One patient - three head and neck primaries:nasopharyngeal, tongue and thyroid cancers. BMC Research Notes 2013, 6:432-438. (http://www.biomedcentral.com/1756-0500/6/432)

52. Khalid Hussain AL-Qahtani, Mushabbab Al Asiri, Mutahir A. Tunio, Naji J Aljohani, Yasser Bayoumi, and Khalid Riaz. Involvement of Parathyroid Glands by Differentiated Thyroid Cancers and its Influence on Treatment Outcome. Thyroid Disorders Ther; 2014 (3) No2:1-4. (http://dx.doi.org/10.4172/2167-7948.1000153)

53. Ahmed Maklad, Yasser Bayoumi, Mutahir Tunio, Wafaa AlShakweer, Mashooque A. Dahar, and Shomaila A. Akbar. Steroid- Resistant Extranodal Rosai-Dorfman Disease of Cheek Mass and Ptosis Treated with Radiation Therapy. Case Reports in Hematology. 2013,1-4. (http://dx.doi.org/10.1155/2013/428297)

22 CV Dr Yasser Bayoumi 12/2014 54. Mutaher Tunio, Mushabbab AlAsiri, Yasser Bayoumi, Ali Balbaid, Mageed Alhamed, Laura stansciu, Ahmed Amer. Lumbosacral Plexus Delineation, Dose Distribution and its Correlation with Radiation-Induced Lumbosacral Plexopathy in Cervical Cancer Patients. OncoTargets and Therapy, 2014. 55. Mushabbab AlAsiri, Mutaher Tunio, Naji Aljohani, Yasser Bayoumi, Wafa Alshaqweer. Diffuse Sclerosing Variant, Papillary thyroid carcinoma: clinicopathological and treatment outcome analysis of 44

cases. KMJ,2014:10,1-6. 56. Yasser Bayoumi, Aida Radwan. Low Dose Total Body Irradiation for Relapsed Low Grade non-Hodgkin’s Lymphoma: Experience of National Cancer Institute, Cairo. Journal of Cancer Therapy, 2014, 12, (http://dx.doi.org/10.4236/jct.2014.53031).

57. Yasser Bayoumi, Reham Abdulmoniem, Abdullah Alamro. Stereotactic Radiosurgery for Functional, Pain, and Other Disorders. Chapter 131 Neurosurgery tricks of the trades book 2013 Thiemes Medical Publisher. ISBN: 978-1-60406-335-6

58. Abdulrahman Alsultan, Musa Alharbi, Sadeq Al-Dandan, Yasser Bayoumi, Talal Alharbi, Reem Alsudairy, Alomari, Ali, Khalid Aljamaan, Othman Musleh, Qasim Alharbi, Mohammed Jarrar. High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors. Journal of Pediatric Hematology/Oncology; December 2014